Martin Kolb

Martin Kolb

McMaster University - Hamilton / Canada
Others
AD Scientific Index ID: 642214
person_outline Martin Kolb's MOST POPULAR ARTICLES
1-) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisL Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...New England Journal of Medicine 370 (22), 2071-2082, 201435812014
2-) Nintedanib in progressive fibrosing interstitial lung diseasesKR Flaherty, AU Wells, V Cottin, A Devaraj, SLF Walsh, Y Inoue, ...New England Journal of Medicine 381 (18), 1718-1727, 201910472019
3-) Acute exacerbation of idiopathic pulmonary fibrosis. An international working group reportHR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ...American journal of respiratory and critical care medicine 194 (3), 265-275, 20169562016
4-) The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?A Moeller, K Ask, D Warburton, J Gauldie, M KolbThe international journal of biochemistry & cell biology 40 (3), 362-382, 200811152008
5-) Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosisL Wollin, E Wex, A Pautsch, G Schnapp, KE Hostettler, S Stowasser, ...European Respiratory Journal 45 (5), 1434-1445, 20159942015